Related references
Note: Only part of the references are listed.Knockdown of Long Non-coding RNA TUG1 Suppresses Migration and Tube Formation in High Glucose-Stimulated Human Retinal Microvascular Endothelial Cells by Sponging miRNA-145
Qian Shi et al.
MOLECULAR BIOTECHNOLOGY (2022)
MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS
Federica Barutta et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p Are Novel Biomarkers for Diagnosis of Acute Myocardial Infarction
Sheng Xue et al.
FRONTIERS IN PHYSIOLOGY (2019)
MicroRNA-145 Involves in the Pathogenesis of Renal Vascular Lesions and May Become a Potential Therapeutic Target in Patients with Juvenile Lupus Nephritis
Zhaomin Cai et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
MiR-145-5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16
Junbiao Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
MicroRNA-145 attenuates high glucose-induced oxidative stress and inflammation in retinal endothelial cells through regulating TLR/NF-κB signaling
Ying Hui et al.
LIFE SCIENCES (2018)
MicroRNA and Microvascular Complications of Diabetes
F. Barutta et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
MicroRNA and Diabetic Complications: A Clinical Perspective
Baoqi Fan et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study
Federica Barutta et al.
ACTA DIABETOLOGICA (2017)
Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease
Julien Faccini et al.
SCIENTIFIC REPORTS (2017)
MicroRNA as Biomarkers and Diagnostics
Jin Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Gasotransmitters in Vascular Complications of Diabetes
Joost C. van den Born et al.
DIABETES (2016)
MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy
Kenshi Higashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Circulating TGF-β1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes
Marcus G. Pezzolesi et al.
DIABETES (2015)
Angiotensin II Downregulates MicroRNA-145 to Regulate Kruppel-like Factor 4 and Myocardin Expression in Human Coronary Arterial Smooth Muscle Cells under High Glucose Conditions
Kou-Gi Shyu et al.
MOLECULAR MEDICINE (2015)
Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease
Hai Gao et al.
PLOS ONE (2015)
MicroRNA miR145 Regulates TGFBR2 Expression and Matrix Synthesis in Vascular Smooth Muscle Cells
Ning Zhao et al.
CIRCULATION RESEARCH (2015)
Endothelial Junctional Adhesion Molecule-A Guides Monocytes Into Flow-Dependent Predilection Sites of Atherosclerosis
Martin M. N. Schmitt et al.
CIRCULATION (2014)
Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension
J. E. Kontaraki et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Mechanical Stretch Suppresses microRNA-145 Expression by Activating Extracellular Signal-Regulated Kinase 1/2 and Upregulating Angiotensin-Converting Enzyme to Alter Vascular Smooth Muscle Cell Phenotype
Bo Hu et al.
PLOS ONE (2014)
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients
Donato Santovito et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Expression profiles of miRNAs in polarized macrophages
Yingying Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
Federica Barutta et al.
PLOS ONE (2013)
Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina
Yuri D'Alessandra et al.
PLOS ONE (2013)
MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients
Kai Doberstein et al.
NEOPLASIA (2013)
Role of microRNAs in diabetes and its cardiovascular complications
Saran Shantikumar et al.
CARDIOVASCULAR RESEARCH (2012)
NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study
Gabriella Gruden et al.
DIABETES CARE (2012)
MICRORNA 143-145 DEFICIENCY IMPAIRS VASCULAR FUNCTION
G. D. Norata et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Eduard Hergenreider et al.
NATURE CELL BIOLOGY (2012)
The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells
Shintaro Yamaguchi et al.
ATHEROSCLEROSIS (2011)
Transforming Growth Factor-β1 (TGF-β1) Utilizes Distinct Pathways for the Transcriptional Activation of MicroRNA 143/145 in Human Coronary Artery Smooth Muscle Cells
Xiaochun Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Kasey C. Vickers et al.
NATURE CELL BIOLOGY (2011)
Circulating MicroRNAs in Patients With Coronary Artery Disease
Stephan Fichtlscherer et al.
CIRCULATION RESEARCH (2010)
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Nobuyoshi Kosaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Serum microRNAs as non-invasive biomarkers for cancer
Jan C. Brase et al.
MOLECULAR CANCER (2010)
The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease
L. Ella et al.
CELL DEATH AND DIFFERENTIATION (2009)
MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation
Yunhui Cheng et al.
CIRCULATION RESEARCH (2009)
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster
Thomas Boettger et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
Kimberly R. Cordes et al.
NATURE (2009)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Diabetic retinopathy is associated with mortality and cardiovascular disease incidence - The EURODIAB prospective complications study
MV van Hecke et al.
DIABETES CARE (2005)
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes - the EURODIAB Prospective Complications Study
MT Schram et al.
DIABETOLOGIA (2005)
Circulating and urinary transforming growth factor β1, Amadori albumin, and complications of type 1 diabetes -: The EURODIAB Prospective Complications Study
N Chaturvedi et al.
DIABETES CARE (2002)
Trends in hypertension management in Type I diabetes across Europe, 1989/1990-1997/1999
SS Soedamah-Muthu et al.
DIABETOLOGIA (2002)
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study
N Chaturvedi et al.
DIABETES CARE (2001)
Share Paper
